- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Vaccine Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Vaccine Adjuvants market size is estimated to be worth US$ 877.5 million in 2021 and is forecast to a readjusted size of USD 1564.6 million by 2028 with a CAGR of 8.6% during review period. Human Vaccine accounting for % of the Vaccine Adjuvants global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Aluminum Adjuvant segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, and Novavax, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vaccine Adjuvants market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aluminum Adjuvant
Emulsions Adjuvant
Others
Market segment by Application can be divided into
Human Vaccine
Veterinary Vaccine
The key market players for global Vaccine Adjuvants market are listed below:
GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales, revenue and global market share of Vaccine Adjuvants from 2019 to 2022.
Chapter 3, the Vaccine Adjuvants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine Adjuvants.
Chapter 13, 14, and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine Adjuvants Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine Adjuvants Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Global Vaccine Adjuvants Market Size & Forecast
1.4.1 Global Vaccine Adjuvants Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Vaccine Adjuvants Sales in Volume (2017-2028)
1.4.3 Global Vaccine Adjuvants Price (2017-2028)
1.5 Global Vaccine Adjuvants Production Capacity Analysis
1.5.1 Global Vaccine Adjuvants Total Production Capacity (2017-2028)
1.5.2 Global Vaccine Adjuvants Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine Adjuvants Market Drivers
1.6.2 Vaccine Adjuvants Market Restraints
1.6.3 Vaccine Adjuvants Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Vaccine Adjuvants Product and Services
2.1.4 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL Limited
2.2.1 CSL Limited Details
2.2.2 CSL Limited Major Business
2.2.3 CSL Limited Vaccine Adjuvants Product and Services
2.2.4 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Croda
2.3.1 Croda Details
2.3.2 Croda Major Business
2.3.3 Croda Vaccine Adjuvants Product and Services
2.3.4 Croda Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 SEPPIC
2.4.1 SEPPIC Details
2.4.2 SEPPIC Major Business
2.4.3 SEPPIC Vaccine Adjuvants Product and Services
2.4.4 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novavax
2.5.1 Novavax Details
2.5.2 Novavax Major Business
2.5.3 Novavax Vaccine Adjuvants Product and Services
2.5.4 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 SPI Pharma
2.6.1 SPI Pharma Details
2.6.2 SPI Pharma Major Business
2.6.3 SPI Pharma Vaccine Adjuvants Product and Services
2.6.4 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Phibro
2.7.1 Phibro Details
2.7.2 Phibro Major Business
2.7.3 Phibro Vaccine Adjuvants Product and Services
2.7.4 Phibro Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 SDA BIO
2.8.1 SDA BIO Details
2.8.2 SDA BIO Major Business
2.8.3 SDA BIO Vaccine Adjuvants Product and Services
2.8.4 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Invivogen
2.9.1 Invivogen Details
2.9.2 Invivogen Major Business
2.9.3 Invivogen Vaccine Adjuvants Product and Services
2.9.4 Invivogen Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Tj Kaiwei
2.10.1 Tj Kaiwei Details
2.10.2 Tj Kaiwei Major Business
2.10.3 Tj Kaiwei Vaccine Adjuvants Product and Services
2.10.4 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 OZ Biosciences
2.11.1 OZ Biosciences Details
2.11.2 OZ Biosciences Major Business
2.11.3 OZ Biosciences Vaccine Adjuvants Product and Services
2.11.4 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Brenntag Biosector
2.12.1 Brenntag Biosector Details
2.12.2 Brenntag Biosector Major Business
2.12.3 Brenntag Biosector Vaccine Adjuvants Product and Services
2.12.4 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 MVP Laboratories
2.13.1 MVP Laboratories Details
2.13.2 MVP Laboratories Major Business
2.13.3 MVP Laboratories Vaccine Adjuvants Product and Services
2.13.4 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Zhuoyue
2.14.1 Zhuoyue Details
2.14.2 Zhuoyue Major Business
2.14.3 Zhuoyue Vaccine Adjuvants Product and Services
2.14.4 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Aphios
2.15.1 Aphios Details
2.15.2 Aphios Major Business
2.15.3 Aphios Vaccine Adjuvants Product and Services
2.15.4 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Vaccine Adjuvants Breakdown Data by Manufacturer
3.1 Global Vaccine Adjuvants Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Vaccine Adjuvants Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Vaccine Adjuvants
3.4 Market Concentration Rate
3.4.1 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2021
3.4.2 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2021
3.5 Global Vaccine Adjuvants Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Vaccine Adjuvants Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vaccine Adjuvants Market Size by Region
4.1.1 Global Vaccine Adjuvants Sales in Volume by Region (2017-2028)
4.1.2 Global Vaccine Adjuvants Revenue by Region (2017-2028)
4.2 North America Vaccine Adjuvants Revenue (2017-2028)
4.3 Europe Vaccine Adjuvants Revenue (2017-2028)
4.4 Asia-Pacific Vaccine Adjuvants Revenue (2017-2028)
4.5 South America Vaccine Adjuvants Revenue (2017-2028)
4.6 Middle East and Africa Vaccine Adjuvants Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Vaccine Adjuvants Sales in Volume by Type (2017-2028)
5.2 Global Vaccine Adjuvants Revenue by Type (2017-2028)
5.3 Global Vaccine Adjuvants Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Vaccine Adjuvants Sales in Volume by Application (2017-2028)
6.2 Global Vaccine Adjuvants Revenue by Application (2017-2028)
6.3 Global Vaccine Adjuvants Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Vaccine Adjuvants Sales by Type (2017-2028)
7.2 North America Vaccine Adjuvants Sales by Application (2017-2028)
7.3 North America Vaccine Adjuvants Market Size by Country
7.3.1 North America Vaccine Adjuvants Sales in Volume by Country (2017-2028)
7.3.2 North America Vaccine Adjuvants Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Vaccine Adjuvants Sales by Type (2017-2028)
8.2 Europe Vaccine Adjuvants Sales by Application (2017-2028)
8.3 Europe Vaccine Adjuvants Market Size by Country
8.3.1 Europe Vaccine Adjuvants Sales in Volume by Country (2017-2028)
8.3.2 Europe Vaccine Adjuvants Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Vaccine Adjuvants Sales by Type (2017-2028)
9.2 Asia-Pacific Vaccine Adjuvants Sales by Application (2017-2028)
9.3 Asia-Pacific Vaccine Adjuvants Market Size by Region
9.3.1 Asia-Pacific Vaccine Adjuvants Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Vaccine Adjuvants Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Vaccine Adjuvants Sales by Type (2017-2028)
10.2 South America Vaccine Adjuvants Sales by Application (2017-2028)
10.3 South America Vaccine Adjuvants Market Size by Country
10.3.1 South America Vaccine Adjuvants Sales in Volume by Country (2017-2028)
10.3.2 South America Vaccine Adjuvants Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vaccine Adjuvants Sales by Type (2017-2028)
11.2 Middle East & Africa Vaccine Adjuvants Sales by Application (2017-2028)
11.3 Middle East & Africa Vaccine Adjuvants Market Size by Country
11.3.1 Middle East & Africa Vaccine Adjuvants Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Vaccine Adjuvants Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Vaccine Adjuvants and Key Manufacturers
12.2 Manufacturing Costs Percentage of Vaccine Adjuvants
12.3 Vaccine Adjuvants Production Process
12.4 Vaccine Adjuvants Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Vaccine Adjuvants Typical Distributors
13.3 Vaccine Adjuvants Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Vaccine Adjuvants Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Vaccine Adjuvants Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Vaccine Adjuvants Product and Services
Table 6. GSK Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 8. CSL Limited Major Business
Table 9. CSL Limited Vaccine Adjuvants Product and Services
Table 10. CSL Limited Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Croda Basic Information, Manufacturing Base and Competitors
Table 12. Croda Major Business
Table 13. Croda Vaccine Adjuvants Product and Services
Table 14. Croda Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. SEPPIC Basic Information, Manufacturing Base and Competitors
Table 16. SEPPIC Major Business
Table 17. SEPPIC Vaccine Adjuvants Product and Services
Table 18. SEPPIC Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novavax Basic Information, Manufacturing Base and Competitors
Table 20. Novavax Major Business
Table 21. Novavax Vaccine Adjuvants Product and Services
Table 22. Novavax Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. SPI Pharma Basic Information, Manufacturing Base and Competitors
Table 24. SPI Pharma Major Business
Table 25. SPI Pharma Vaccine Adjuvants Product and Services
Table 26. SPI Pharma Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Phibro Basic Information, Manufacturing Base and Competitors
Table 28. Phibro Major Business
Table 29. Phibro Vaccine Adjuvants Product and Services
Table 30. Phibro Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. SDA BIO Basic Information, Manufacturing Base and Competitors
Table 32. SDA BIO Major Business
Table 33. SDA BIO Vaccine Adjuvants Product and Services
Table 34. SDA BIO Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Invivogen Basic Information, Manufacturing Base and Competitors
Table 36. Invivogen Major Business
Table 37. Invivogen Vaccine Adjuvants Product and Services
Table 38. Invivogen Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Tj Kaiwei Basic Information, Manufacturing Base and Competitors
Table 40. Tj Kaiwei Major Business
Table 41. Tj Kaiwei Vaccine Adjuvants Product and Services
Table 42. Tj Kaiwei Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. OZ Biosciences Basic Information, Manufacturing Base and Competitors
Table 44. OZ Biosciences Major Business
Table 45. OZ Biosciences Vaccine Adjuvants Product and Services
Table 46. OZ Biosciences Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table 48. Brenntag Biosector Major Business
Table 49. Brenntag Biosector Vaccine Adjuvants Product and Services
Table 50. Brenntag Biosector Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. MVP Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. MVP Laboratories Major Business
Table 53. MVP Laboratories Vaccine Adjuvants Product and Services
Table 54. MVP Laboratories Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Zhuoyue Basic Information, Manufacturing Base and Competitors
Table 56. Zhuoyue Major Business
Table 57. Zhuoyue Vaccine Adjuvants Product and Services
Table 58. Zhuoyue Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Aphios Basic Information, Manufacturing Base and Competitors
Table 60. Aphios Major Business
Table 61. Aphios Vaccine Adjuvants Product and Services
Table 62. Aphios Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Vaccine Adjuvants Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 64. Global Vaccine Adjuvants Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Vaccine Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Vaccine Adjuvants Production Capacity by Company, (MT): 2020 VS 2021
Table 67. Head Office and Vaccine Adjuvants Production Site of Key Manufacturer
Table 68. Vaccine Adjuvants New Entrant and Capacity Expansion Plans
Table 69. Vaccine Adjuvants Mergers & Acquisitions in the Past Five Years
Table 70. Global Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
Table 71. Global Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
Table 72. Global Vaccine Adjuvants Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Vaccine Adjuvants Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
Table 75. Global Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
Table 76. Global Vaccine Adjuvants Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Vaccine Adjuvants Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Vaccine Adjuvants Price by Type (2017-2022) & (USD/Kg)
Table 79. Global Vaccine Adjuvants Price by Type (2023-2028) & (USD/Kg)
Table 80. Global Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
Table 81. Global Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
Table 82. Global Vaccine Adjuvants Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Vaccine Adjuvants Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Vaccine Adjuvants Price by Application (2017-2022) & (USD/Kg)
Table 85. Global Vaccine Adjuvants Price by Application (2023-2028) & (USD/Kg)
Table 86. North America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
Table 87. North America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
Table 88. North America Vaccine Adjuvants Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Vaccine Adjuvants Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
Table 91. North America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
Table 92. North America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
Table 93. North America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
Table 94. Europe Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
Table 95. Europe Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
Table 96. Europe Vaccine Adjuvants Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Vaccine Adjuvants Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
Table 99. Europe Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
Table 100. Europe Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
Table 101. Europe Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
Table 102. Asia-Pacific Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
Table 103. Asia-Pacific Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
Table 104. Asia-Pacific Vaccine Adjuvants Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Vaccine Adjuvants Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
Table 107. Asia-Pacific Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
Table 108. Asia-Pacific Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
Table 109. Asia-Pacific Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
Table 110. South America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
Table 111. South America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
Table 112. South America Vaccine Adjuvants Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Vaccine Adjuvants Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
Table 115. South America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
Table 116. South America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
Table 117. South America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
Table 118. Middle East & Africa Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
Table 119. Middle East & Africa Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
Table 120. Middle East & Africa Vaccine Adjuvants Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Vaccine Adjuvants Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
Table 123. Middle East & Africa Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
Table 124. Middle East & Africa Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
Table 125. Middle East & Africa Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
Table 126. Vaccine Adjuvants Raw Material
Table 127. Key Manufacturers of Vaccine Adjuvants Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Vaccine Adjuvants Typical Distributors
Table 131. Vaccine Adjuvants Typical Customers
List of Figures
Figure 1. Vaccine Adjuvants Picture
Figure 2. Global Vaccine Adjuvants Revenue Market Share by Type in 2021
Figure 3. Aluminum Adjuvant
Figure 4. Emulsions Adjuvant
Figure 5. Others
Figure 6. Global Vaccine Adjuvants Revenue Market Share by Application in 2021
Figure 7. Human Vaccine
Figure 8. Veterinary Vaccine
Figure 9. Global Vaccine Adjuvants Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Vaccine Adjuvants Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Vaccine Adjuvants Sales (2017-2028) & (MT)
Figure 12. Global Vaccine Adjuvants Price (2017-2028) & (USD/Kg)
Figure 13. Global Vaccine Adjuvants Production Capacity (2017-2028) & (MT)
Figure 14. Global Vaccine Adjuvants Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Vaccine Adjuvants Market Drivers
Figure 16. Vaccine Adjuvants Market Restraints
Figure 17. Vaccine Adjuvants Market Trends
Figure 18. Global Vaccine Adjuvants Sales Market Share by Manufacturer in 2021
Figure 19. Global Vaccine Adjuvants Revenue Market Share by Manufacturer in 2021
Figure 20. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Vaccine Adjuvants Sales Market Share by Region (2017-2028)
Figure 24. Global Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
Figure 25. North America Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
Figure 26. Europe Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
Figure 28. South America Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
Figure 30. Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 31. Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
Figure 32. Global Vaccine Adjuvants Price by Type (2017-2028) & (USD/Kg)
Figure 33. Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 34. Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
Figure 35. Global Vaccine Adjuvants Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 37. North America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 38. North America Vaccine Adjuvants Sales Market Share by Country (2017-2028)
Figure 39. North America Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
Figure 40. United States Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 44. Europe Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 45. Europe Vaccine Adjuvants Sales Market Share by Country (2017-2028)
Figure 46. Europe Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
Figure 47. Germany Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Vaccine Adjuvants Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Vaccine Adjuvants Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
Figure 56. China Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 63. South America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 64. South America Vaccine Adjuvants Sales Market Share by Country (2017-2028)
Figure 65. South America Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Vaccine Adjuvants Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Vaccine Adjuvants in 2021
Figure 77. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 78. Vaccine Adjuvants Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
